Investigating how a specific chloride channel affects bacterial pneumonia and sepsis
The Role of Proton-Activated Chloride Channel 1 (PACC1) in Bacterial Pneumonia and Sepsis
This study is looking at a new channel in our immune cells that might help us fight off bacterial infections like pneumonia and sepsis, and it's for anyone interested in how our bodies defend against these illnesses.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10998794 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a newly discovered chloride channel, PACC1, in the immune response to bacterial infections, particularly pneumonia and sepsis. The study examines how this channel influences the function of immune cells, specifically alveolar macrophages, which are crucial for fighting off bacterial threats. By using genetically modified mice that lack PACC1, researchers aim to uncover its importance in the acidification of phagolysosomes, a key process in destroying bacteria. The findings could lead to new insights into potential therapeutic targets for treating bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with bacterial pneumonia or sepsis, particularly those who may have underlying immune response issues.
Not a fit: Patients with viral infections or non-infectious conditions are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the immune response against bacterial pneumonia and sepsis.
How similar studies have performed: While the specific role of PACC1 in bacterial immunity is novel, similar research on chloride channels has shown promise in understanding immune responses.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Garo, Lucien Peter — Boston University Medical Campus
- Study coordinator: Garo, Lucien Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.